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To localize epidermal growth factor (EGF) receptors 
in normal human epidermis and other skin structures, 
two different light microscopic methods were used. EGF 
binding ([ 125I]EGF/R) to the extracellular portion of the 
EGF receptor was studied by incubating intact skin 
samples with [1 2 5 l]EGF, sectioning the tissues, and per-
forming autoradiography. Immunoreactive EGF recep-
tor molecules (IR-EGF/R) were localized with a mono-
specific anti-EGF receptor antibody using a 2-step in-
direct immunocytochemical method (horseradish per-
oxidase) and detergent permeabilized tissues. This latter 
method measured the total pool of EGF receptors: occu-
pied and/or internalized forms, precursor forms, and 
partially degraded forms of the EGF receptor that retain 
immunoreactivity. Both the [125I]EGF/R and IR-EGF/R 
localization studies indicated that EGF receptors were 
present in basal epidermal keratinocytes, sebocytes, 
outer root sheath cells in hair follicles, smooth muscle 
cells of arrector pili muscles, and dermal arteries. The 
highest levels of [125I ]EGF/R and IR-EGF/R were found 
in the dermal ducts of eccrine sweat glands. The distri-
bution of both [12"I]EGF/R and IR-EGF/R was not con-
sistent with the concept that EGF exclusively is involved 
in cellular division and proliferation in normal human 
epidermis and its appendages, i.e., EGF receptors were 
also found in tissues that do not undergo rapid prolifer-
ation. The present study indicates that EGF may have a 
more complex regulatory role in the skin than was pre-
viously thought. 
Morphologic studies of epidermal growth factor (EGF) recep-
tors in mammalian skin have been relatively overlooked in view 
of t he evidence t hat skin is a major target for EGF action. Early 
studies indicated that EGF caused a t hickening of neonatal 
epidermis in vivo [1] and in organ culture [2,3]. Although skin 
is a preferred site for EGF binding [4], the cell type responsible 
for EGF binding within this complex organ could not be pre-
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cisely determined using homogenized skin. O'Keefe et al later 
demonstrated EGF binding in neonatal mouse epidermis [5] 
and subsequently in cu ltured keratinocytes [6]. These studies 
showed that EGF binding in cultured cells decreased as t he 
intact, viable keratinocytes became more differentiated. 
In our initial studies [7]. we showed t hat [12"'I]EGF binding 
sites as measured by light microscopic autoradiography were 
predominately on t he basal keratinocytes and decreased in t he 
upper, more differentiated epidermal laye rs. Since (125l]EGF 
was incubated with small blocks of intact skin prior to section-
ing, the light microscopic autoradiographic approach detected 
only t hose EGF receptors located on t he extracellular surface 
([ 1 ~"I]EGF/R). This [12' I]EGF binding method may underesti-
mate the extracellular EGF receptor population because bind-
ing is subject to affinity changes [8-12]. cryptic receptors may 
be unmasked by changes in calcium [13]. and it does not detect 
the intracellular pool of receptors. In vitro locali zation studies 
have shown that after initial binding to receptors on the plasma 
membrane, labeled EGF is internalized progressively by the 
cells in a time- and temperature-dependent fashion, resulting 
in an intracellular pool [14,15]. The EGF receptor complex 
undergoes surface clustering, endocytosis, and degradation and/ 
or recycling [16- 19]. Conversely, t he intracellular synthesis of 
EGF receptors may occur at a rapid rate approaching 72,000 
molecules/h in some cells; t his represents 12% of the total EGF 
receptor population in A-431 cells. 1" Thus in cells that are 
constantly exposed to EGF, only a portion of the EGF receptor 
population would be associated with the plasma membrane and 
the rest would be found as cryptic, precursor, and internali zed 
receptors. 
To detect the total pool of EGF intracellular and extracellular 
receptors, an immunocytochemical tec hnique was used on de-
tergent-treated, cryostat sections of human skin . In t he present 
report, we compare the distribution of immunoreactive recep-
tors in detergent-treated samples as determined by immuno-
cytochemistry (IR-EGF/ R) with t he extracellular receptor pop-
ulation available for [' 2''I]EGF binding ([ 125l]EGF / R) in normal 
human skin and epidermal appendages. 
MATERIALS AND METHODS 
Reagents 
EGF was purchased from Coll aborative Research (Waltham, Mas-
sachusetts) , and [ 12r, l] was obta ined from New England Nuclear (Bos-
ton, Massachusetts). NTB-2 autoradiography emulsion was obtained 
from Eastman Kodak (Rochester, New York). Goat ant.irabb it lgG 
conjugated to horseradish peroxidase was purchased from Miles Labo-
ratories (Elkhart, Indiana). The supply of 3,3-diaminobenzidine (DAB) 
was from Sigma Chemical Company (St. Louis, Missouri) . Calf serum 
and Dulbecco's modified Eagle's medium (DMEM) were purchased 
from GIBCO (Grand Island, New York). All other reagents were 
purchased from common suppliers and were of reagent grade. 
Localization of f 1251] EGF Binding by Autoradiography 
Control experiments: EGF was labeled with '2' I by the chloramine-T 
method, as previously described [20], to a specific activity of 1.5 X 10" 
t Stoscheck CM, Soderquist AM, Carpenter G: Biosynthesis of the 
EGF receptor in human cells. Submitted for publication. 
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counls/min//lg. The ['"5IJ EGF bound to A-431 membranes and fibro-
blasts in a co ncent ration-dependent, saturable a nd reversible manner 
121] . EGF labeled by t his method was shown to be biologically active 
as determined hy its capacity to cause a n increase in ce ll number, [aH] 
t hymidine uptake, and EGF receptor prote in kinase activity [20] . 
Excess un labeled (2 I' g) EGF was added afte r [ m'l] EGF binding (re-
versibili ty test) to show t he extent of nonspecific or nonclisplaceable 
radioactivity (see Fig 1C). 
Experimental method used: Localizat ion of [m' J]EGF binding by 
auto radiography in sec t ions of human skin was performed as previously 
describecl i5J. In brief, skin samples were sli ced in to ve ry sma ll pieces 
(1 mm"). Samples were incuba ted for 90 min at 25 ' C with shaking in a 
medium cons istin g of 0.5 ml Hanks' ba lanced salt. so lu tion conta ining 
1 mg/m l bovine se rum a lbumin , 20 mM H EPES, pH 7.4, ancl 10 ng/ml 
[' 2'' IJEGF. Unbound EGF was removed by repea ted washes in t he 
a lbu min conta ining sa lt so lu t ion at 2f ' C. Alte rna tive ly, some samples 
were incubated for 90 min in medium co nta ining excess unlabeled EGF 
(2 i<g/m l) a fte r incubation with [' 2"I] EGF (reve rsibili ty Lest ). All s kin 
samples were li xecl for 4 h in 10% neutral buffe red fo rmalin a nd 
processed for light microscopy in pa raffin. Sections (7 I'm) were clipped 
in a 1:1 mi xture of NTB-2 emulsion and d istill ed wate r. Following 
exposure at. 4' C fo r 4- 12 weeks, t he emulsion was developed for 2 min 
in Kodak D-19 developer a t. l.O ' C. Sections were lightly sta ined with 
hematoxylin a nd eosin and mounted in Permoun t . Photographs were 
made using an Olympus PM -10-M microscope with both bright -field 
and da rk -fi eld illumination. 
EGF Receptor Antiserum-Production and Characterization 
T he affinity-purified EGF receptor prepa rat ion, used to immunize 
rabbits to produce a specific ant ise rum to the receptor, was prepared 
as previously desc ribed [22- 24]. Brie fl y, t he EGF receptors from A-4:H 
human epitheloicl ca rci noma membrane vesicles were solubili zed a nd 
placed on an EG F a ffin ity colum n. The receptor was elu t.ecl with 5 mM 
et. hanolamine, pH 9.7, conta ining 10% glyce rol and 0.2% Triton X-100 
and t.hen elect.rophoresecl by the method of Laemm li [2.5 ]. The Coom-
assie Blue sta ined recepto r band was t hen cut out and approximate ly 
5 l'g receptor prote in injected into the rahb it. in complete Freund 's 
adjuvant.. One week late r, a ntise rum collection was begun . The lgG 
fraction of t he antise rum was purified by ammonium sulfate precipi -
ta tion 126]. 
Localization of i mmunoreactive EGF Receptor Molecules 
Control experiments: Prelimi na ry experiments estab lished t hat when 
the immunocy t.ochemical horse radis h peroxidase method was used, 
endogenous perox idase was present in t he perinuclea r region and 
mi tochondria of suprabasa l kerat.inocyles 127] and neutrophi ls [28]. 
After treating with 2.5% glu tara ldehyde to inhibi t. t hi s type of endoge-
nous pe rox idase 128 1. t he residua l gluta raldehyde insens itive peroxidase 
was found only in t.he stra tum (s.) granu losum of thick epidermis. S ince 
normal and d iseased human skin (psoria: is, lupus eryl hematosus, and 
other inflammatory disorders) may have deposits of lgG, some con t rol 
sections were a lso treated with preimmune JgG followed by secondar·y 
antibody. Low levels of DAB reaction product were detected in a ll 
preimmune lgG-treated sec ti ons of normal skin . In a ll such cases, t his 
nonspecifi c activity due to lgG deposits was much lower t han peroxi -
dase activ ity clue to t he specific antibody binding to t he EGF receptor. 
!ixperimenlalmethod fo r tissues: No rmal skin specimens from s ites 
of t hick palmar sk in and t hin breast skin were co llect.ed from patie nts 
undergoin g elective pl astic surgery at Vanderbil t or Veterans Admin -
istration Medical Cente rs in Nas hvill e, T ennesee. Cryostat sec tioned 
!.issue sa mples (4 - 6 11 m) were fixed in 2.5 % gluta ra ldehyde in phos-
phat.e-bufTerecl saline (PBS), pH 7.4, for 15 min at 4' C. The sect ions 
were rinsed a nd then in cubated 15 min with DMEM conta ining 10% 
ca lf se rum and 0.05% Triton X-100 to decrease nonspecific b inding 
and permeabilize t he fi xed ce lls ]29]. Sections were treated for 4 h a t. 
4' C with either PBS, pur ifi ed normal rabbi t lgG or ant i-EGF recepto r 
lgG diluted to 0.05 mg/ ml in 10% calf se rum in DMEM conta ining 
0.05 % Triton X- 100. After ex tens ive washing, the sections were incu-
bated for 1 h wit.h goal a ntirahbit lgG co njugated to horse ra dish 
perox idase di lu ted 1:100 in 10% calf se rum in DMEM with 0.05% 
Triton X- 100. Finally, a fter ex tens ive washing, t issue sec tions were 
reacted with 0.05 % DAB and 0.01% H"O" in 0.05 M Tris buffer, pH 
7.6. 
RESULTS 
[ 1"r'l]EGF Binding in Epidermis 
In norma l t hick a nd t h in epide rmis, t he s ilve r grains indi ca-
t ing t he location of [12''I]EGF we re distributed m ostly over t he 
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basal ke ratinocytes of t he epide rmis a nd progressive ly d e-
creased in the s. spinosum a nd s . granulosum to reac h back-
ground levels in the oute rmost s. corn eu m . F ew s ilver grain s 
were observed in the relative ly acellular de rmi s as compare d to 
t he epidermis in t he expe rime nta l samples, but the numbe r of 
s ilve r gra ins was clearly high er t h a n t ha t seen in con t r o l 
samples (com pare Fig lA and C). This ve ry low leve l of [' 25IJ 
F IG 1. Autoradiograph or normal t hin epide rmis from the breast 
region. Tissue was incubated with [125 l] EGF as described in Materials 
and Methods and the exposu re t ime = 10 weeks. A, Dark-field view of 
l'"5I]EGF binding shows a marked concentra tion of silve r grains over 
s. basa lis (b ) (see in B). Greatly reduced cell labe ling is noted over t he 
s. granulosum (g) a nd s . corneum (c). B, Co rresponding bright-field 
view. E = epidermis, D = dermis. Calibration bar = 50 J1111. C, Oa rk-
lield view of [' "' l] EGF binding followed by excess unlabe led EGF 
binding. A random dispersion of s ilver grains is seen ove r both dermis 
and epidermis. 
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FIG 2 . Aut oradiograph of a sebaceous gland. Tissue was incubated 
in [125I]EGF, as described in Materials and Methods and exposure Lime 
= 10 weeks . ilve r grain distribution is higher over densely cellular 
regions at the periphery of the a lveolus. A, Dark -fie ld view. B, Bright 
fie ld view. Calibration bar= 50 ;on. 
EGF /R observed in the dermis was not due to the fa ilure of 
[' 25I]EGF penetration since various dermal structures such as 
blood vessels, sweat ducts, and muscle cells were highly labeled 
(see below). 
Control incubations: When sections were incubated for 4- 12 
weeks, the amount of background labeling progressively in-
creased in proport ion to the exposure time. The optimal expo-
sure tiiTie to visual ize [ ' ~"I]EGF binding in normal human 
epidermis by autoradiography was found to be approximately 
10 weeks. T o determine whether t he presence of s ilver grains 
represented the binding of [' "'l]EGF to its receptor ([''l'' I]EGF / 
R), the fo llowing experiments were performed. A 100-fold ex-
cess of unlabeled EGF was included in t he wash before or after 
the incubation of t he t issue sample with [' ""I]EGF in order to 
chase specifica lly bound [' 2"I]EGF. The number of s ilver gra ins 
detected by autorad iography in the t issue sections under these 
conditions was considered to be nonspecific binding or back-
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ground radioactivity. The total amoun t of nonspecific binding 
cou nted as s il ve r grai ns localized over keratinocytes was 5% of 
the total binding (Fig 1C). When tissue blocks were first 
exposed to unlabeled EGF and t hen fo llowed by [' 2' I]EGF, no 
detectable differe nce from the normal experimenta l sections 
which were incubated only with [12''I]EGF was observed. There-
fore, the majority of t he grains due to [' 2"I]EGF in t he experi-
mental sections were specifically and reversibly bound to EGF 
receptors ([ 125l]EGF /R). 
[' "''I]EGF/ R in pilosebaceous glands: [' 2''I]EGF binding was 
readily visualized in pilosebaceous structures (Figs 2A,B; 3A,B; 
4A,B) . In the sebaceous glands, the most intense labeling was 
found at the periphery over t he germinative, less differentiated 
population of sebocytes (Fig 2A,B). Less labeling was observed 
in the in terior, central regions where t he more mature, highly 
different iated sebocytes are located (Fig 2A,B). In t he hair 
fo llicle, ['"''I]EGF / R was found predominately on the outer root 
sheath cell s (Fig 4A,B). Little labeling was observed in the 
more di fferentiated keratinized inner root sheath cells. The 
[ 12' I]EGF labeling of ep idermal keratinocytes on t he surface 
appeared continuous with the outer root sheath cells in the 
pilar region (data not shown). Another portion of the pilose-
baceous apparatus showing [' 2·'J]EGF /R was t he arrector pili 
musc le (Fig 3A,B). The binding activity in t hese smooth muscle 
cells was much higher than in the adjacent fibroblasts and 
quantitatively similar to that seen in keratinocytes. 
f '"''I] EGF/R in eccrine sweat glands: Representative longi-
tudinal and cross-sectional views of double- layered cuboidal 
epit helium from the dermal eccrine sweat ducts are shown in 
Fig 5A,B. ['t'I]EGF/R were higher in the eccrine sweat duct 
t han any other epidermal or dermal structure. After only 5 
weeks of exposure time, binding activity was easily detected in 
the dermal eccrine sweat duct, but was not visible in other 
epidermal or dermal structures until approximately 8 weeks 
exposure t ime. Even after longer exposure t imes (8- 12 weeks), 
no binding activity was noted in t he highly differentiated, 
keratinized epidermal regions of sweat ducts nor was binding 
activity detected over the secretory region of eccrine sweat 
gland acini (data not shown). It should be noted that in t he 
eccrine secretory segment, the data obtained from [' ~"I]EGF/R 
differed from IR-EGF /R data. By autoradiography, no [' t'Il 
EGF was detectable in eccrine secretory portions (Fig 5A ,B), 
but by IR-EGF/ R a marked stain precipi tate was visible over 
the myoepithelial cells around the periphery of eccrine sweat 
glands (see below). 
FIG 3. Aut.oradiograph of arrector pili muscles. T issue was incu -
bated in I'2''1]EGF, as described in Materials and Method.< and exposu re 
time= 10 weeks. Si lver grains a re located over the smooth muscle cells 
(M). A, Dark -fie ld view. B, Bright-field view. Calibration bar= 100 ;•m. 
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FIG 4. Autoradiograph of a hair follicle in cross section. Tissue was 
incubated in ["'TJ EGF, as described in Material"' and Method~ and 
exposure time= 7 weeks. Sil ver gra ins W2''T]EGF binding) are present 
on the ex ternal root sheath cells (E) . A reduction in silver grain density 
is apparent over the inner ce ll layers. Note the absence of labeling over 
the hair (H). A, Dark-fi eld view. B, Bright-fi eld view. Calibration bar 
= l0011m. 
Localization of Immunoreactive EGF Receptors 
Anti-EGF receptor properties: The polyclonal a ntiserum 
(#163) against the human EGF receptor was produced in a 
rabbit using affini ty-purified EGF receptor [22-24]. As previ-
ously described [23], this a ntiserum specifically immunoprecip-
itates both the M, = 170,000 an d the Mr = 150,000 forms of 
the EGF receptor as well as t he intracellular EGF receptor Mr 
= 160,000 precursor form but not [12''1]EGF. This f/163 EGF 
receptor antibody blocked [' "'l]EGF binding to its receptor in 
human , rat , and mouse but not rabbit t issues [23]. However, 
[' 2'' I]EGF binding to unoccupied receptors did not prevent 
binding of t he #163 ant ireceptor ant ibody which could immu-
noprecipitate t he [12''I]EGF when and only when it was bound 
to the receptor [23]. 
Control incubations: To ascertain whether t he presence of a 
brown DAB reaction product represented the location of im-
munoreactive EGF receptors (IR-EGF/R), 2 con trols were per-
formed. In one, t he EGF receptor antiserum #163 was replaced 
with normal preimmune rabbit serum (Figs 6B, 7B, 8B, 9B , 
lOB, llB); and in the other, the primary antiserum #163 was 
replaced wi th PBS to determine the endogenous, nonspecific 
reaction product background (data not shown). In some cases, 
some human IgG deposit ion was detected in clinically normal 
skin . However, t his IgG deposition produced only a fa int brown 
reaction product compared to t he marked precipitate noted 
when ant i-EGF receptor antibody was used. 
In t he human dermis, the use of 2.5% glutaraldehyde to fix 
t he t issue reduced the endogenous peroxidase activity present 
in several cell types [27,28]. There was no measurable difference 
between t he glutaraldehyde-tixed and the unfixed t issue rela-
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FIG 5. Autoradiograph of eccrine sweat duct. Tissue was incubated 
in [125l]EGF, as described in Materials and M ethods. ['"'IJEGF binding, 
as evidenced by silver grains, is seen over the double- layered cuboidal 
epithelial ce ll s of the dermal region of the eccrine sweat duct. Note the 
absence of silver grains over the lumen (L). Although th is micrograph 
was taken from a section exposed fo r only 5 weeks, [125l]EGF binding 
of this region was much more intense than other epidermal or derm al 
structures which showed no detectable specific binding at this time. 
The inset shows a cross-sectional view of an eccrine sweat duct after 
the autoradiograph was exposed for 8 weeks. A, Dark-field view. B, 
Bright- fi eld view. Calibration bar = 50 .urn. Inset calibration bar = 25 
.urn. 
tive to keratinocyte labeling in normal human skin . We elected 
to use the glutaraldehyde-fixed tissues s ince many human skin 
diseases have infi ltrating cells known to have high levels of 
endogenous peroxidase. 
Thick and thin epidermis: The localization of immunoreac -
t ive EGF receptors (IR-EGF /R) in thick palmar and thin breast 
epidermis is shown in Figs 6A and 7A, respectively. The distri-
bution of IR-EGF /R was best demonstrated in the s. basalis 
keratinocytes in t hick palmar epidermis (Fig 6A ). The in-
creased number of keratinocytes in the s. corneum helped to 
spatially delineate t he DAB precipitate that was typically seen 
only in t he lowest layer of keratinocytes. In this thick normal 
palmar skin, the s. basalis keratinocytes clearly had a large 
number of IR-EGF/R as indicated by the dense DAB precipi-
tate. No DAB precipitate was detected in the normal s. cor-
neum. The very low amount of DAB precipitate present in t he 
s. granulosum was not due to IR-EGF/ R since t he same amount 
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of endogenous perox idase activi ty was present in IgG control 
sections (Fig 68) and also in the PBS control (data not shown). 
The immunoperoxidase staining of t hin epidermis showed 
the same qua li tative distribut ion of IR-EGF/ R as [' :!'•I]EGF/ R. 
Both methods showed that EGF receptor activi ty was normally 
present in the s. basa li s and absent in the s. corneum. However, 
t h e immunoperox idase method was not as visually prec ise in 
localizing IR-EGF/ R in t hin epidermis as compared to t he [' "''I] 
EGF / R loca lized by t he autoradiography method. Th is differ-
ence was in part due to both lgG deposit ion in the normal s . 
corneum (Fig 68) and the lac k of spatial resolution between 
t h e s t rata in t hin skin. 
In t he dermis, very li ttle endogenous peroxidase activity was 
detected in smooth muscle cells of arterioles (Fig lOB), arrector 
pili muscles (Fig S8 ), or other cell types. Using the an ti-EG F 
receptor immunoperoxidase method, IR-EGF / R were noted in 
arrector pili musc les (Fig SA ) and mooth muscles of dermal 
arteries (Fig lOA). Although in vit ro [' :!' I]EGF binding and 
immunoreactive EGF receptors were readi ly detected in fibro-
blasts [24], no immunoreactive EGF recepto rs were detected in 
dermal fibrob last in s it u in normal human skin. 
Pilosebaceous units: Resul ts of t he IR-EGF/ R localization in 
sebaceous glands a re shown in Fig SA. Note the very low level 
of e ndogenous DAB reaction product in t he control samples 
(Fig 8 B). The IR-EGF/ R were most concentrated around t he 
p e riphery of the sebaceous gland as was prev ious ly shown for 
( 1 2"I]EGF/ R by the autoradiographic method (Fig 2) . This 
diffe renti al loca lization of IR-EGF/ R seems due to both cell 
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density effects and differentiation-induced differences in se-
bocytes. Fig SA also shows that the distribution of IR-EGF / R 
in arrector pili muscle is similar to t hat previously observed for 
[ ' 2"l]EGF/R (Fig 3). 
The immunoperox idase method showed IR-EGF/ R were 
present within several regions of t he hair fo llicles. IR-EGF/ R 
were primarily localized in the outer root sheath cells, and were 
not present in eit her t he inner root sheath layers or keratin ized 
hair portions (Fig 9A ). This distribut ion of IR-EGF/ R was t he 
same using t he ['2"l]EGF/ R (Fig 4). The melanin pigment 
normally found in t he inner portion of the hair was easily 
distinguished from the DAB precipitate in t he outer root sheath 
cells in PBS-incubated control specimens. Also, a high level of 
IR-EGF /R was associated with t he proliferative population of 
hair matrix cells in longitudinal sections of t he dermal papillae 
region of anagen stage hair follic les (data not shown). No 
evidence of immunoreactive EGF receptors was fo und in fibro-
blasts in the connective t issue sheath surrounding the hair 
folli cles. 
Eccrine sweat glands: In sections incubated in anti-EGF 
receptor antiserum, t he DAB reaction product was deposited 
in both the acini and dermal portions of eccrine sweat ducts 
(Fig lOA). In t he sec retory segments, IR-EGF/R were observed 
in the myoepitheli al cells. This is in cont rast to the lack of 
detection by t he [' ~''l]EGF binding technique. Very li ttle pre-
cipitate was seen in secretory cells. Because t he secretory 
epithelial cells were severely disrupted in t he cryostat sections, 
whether EGF receptors were present on secretory cell s in low 
F IG 6. Jmmunoperox idase stai ning of t hick pa lmar epithelium. Cryostat sec tions were cut, treated, and incuba ted wi t h antibodies and reagents 
as described in Ma terials and M ethods. A, DAB reaction product is strongest in t.he downward extensions of t he s. basalis (b) and s. spinosum 
(s ) and m arkedly absenL in t he thickened s. corn eum (c) , indicating t hat EGF recepto rs a re present. on t he proliferating, undiffere ntiated 
kerat inocyt.es and not on t he corneocytes. Tissue was incubated with antireceptor lgG fo r 4 h. B, Cont rol sample incubated in normal rabbit. JgG 
shows a f a in t DAB product in s. basa lis . Calibration bar= 50 iJ.m. 
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Ftc 7. lmmunoperox idase staining of normal th in skin as described 
in Ma terials and Methods. A , Section was incuba ted in EGF receptor 
antibody. DAB reactio n product is in tense over basa l kerat. inocytes (b) 
and appears to be less in the s. spinosum a nd granulosum (arrow). The 
DAB reactio n product in the s. co rneum may represent nonspecific 
background sta ining. H, Section was incubated in lgG control sera. 
High background in the s. co rneum and s. basa lis ca n be attributed to 
nonspecific sta ining in ti ssues. Calibrat ion. bar = 100 f.lm. 
A 
B 
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Fl(: 9. Immunoperoxidase staining of a hair follicle. A, T his exper-
imental section is a representative cross-sectional view t hrough the 
middle region of a hair folli cle. An extremely dense reaction product is 
noted in the cells of the exte rnal root sheath (e ). The inner root sheath 
keratinized cells (i) a re not sta ined. The sta ining of hair (h) is due to 
pigmen tation. ln addition, the assoc ia ted connective tissue sheath 
fibroblasts in the dermis show no staining reaction. B, The l gG control 
section shows diminished reac tivity in the oute r root sheath cells . 
Slight. dense staining of the ha ir is due to the pigmenta tion of mela-
nosomes. Calibration bar = 100 f.lm. 
levels cou ld not be determined accurately. The ductile segment 
of the eccrine sweat gland which is a double-layered cuboidal 
epithelium showed an intense DAB reaction product. Both the 
inner and outer layers of cells appeared to contain IR-EGF /R. 
EGF receptors were not detectable in the highly keratinized 
ep idermal or acrosyringeal region of the duct (data not shown). 
Apocrine swea.t glands: lmmunoperoxidase staining of apo-
crine gland is shown in Fig llA . The secretory epithelium was 
severely disrupted during section ing and incubation. Neverthe-
less, a low level of IR-EGF/R in sections incubated with anti-
serum was observed on t hese cells. As seen in the eccrine sweat 
glands (Fig lOA), t he myoepithelial cells around the periphery 
of the apocrine gland contained a very dense DAB precipitate, 
indicating the presence of IR-EGF /R. 
FIG 8. lmmunoperoxidase staining of a sebaceous gland. A, In the 
experimental section, positively stained ce lls in the a lveolus of a seba-
ceous gland and t he a rrector pili muscle (m) indicate t;hat EGF recep-
tors a re present in bot h structures. B, The lgG control section shows 
diminished reactivity in both the sebaceous gland a nd t he arrector pili 
muscle ti ssue. Calibration bar = 100 f.lm. 
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FI G 10. lmmunoperoxidase sta ining of the eccrine sweat gla nd a nd 
d e rm a l a rtery. A , This experimenta l section s hows DAB precipi tate in 
t h e m yoepi t helia l ce ll s a round the peri phe ry or t he sec retory segments 
of t h e sweat :::la nd (arrows ). The secreto ry epithelium shows a ve ry 
fa in t DAB reaction p roduct .. Heavy sta ining is present in t he do uble-
laye r e d cuboida l epi t helium of the derma l port ion of t he sweat. duct 
(D). T he tunica media (smooth muscle ce ll~) or a dermal artery (a) 
s h ow a definite DAB react ivity. B, T he JgG cont.rol section s how~ no 
DAB precipita te (in porri ons of t.he swea t gla nd or blood vesse l). 
Calibration bar = 100 J.<l11 . 
DI SCUSSION 
In t his study, we have compared t he locali zation of EGF 
binding activity ([' ""I]EGF / R) wit h t hat of immunoreactive 
E G F r eceptors (lR-EGF/ R) localized by an ant i-EGF receptor 
a n t ibo dy method in normal human skin . These approaches 
a llo w e d us to examine different aspects of t he EGF receptor, 
i .e., what cells express or retain specific E GF binding sites in 
vivo o r in vit ro and what cells conta in EGF receptors, even if 
t h e y a re predominate ly intracellular. T he [' ~''I]EGF / R proce-
dure w as performed using small blocks of intact skin incubated 
w it h [ '"''I]EGF prior to t issue sectionin g to show the presence 
of unoccupied or reversibly occupied , accessible binding sites 
on t h e extracellula r surface of intact ce lls. The results of these 
( 125l)EGF binding studies must be considered in t he following 
con text: (1) in t racellula r EGP receptors would not be detected 
by t his method; (2 ) changes of t he receptor affinity or number 
induced by processing could change the binding activi ty. In 
contrast, the IR-EG F / R method should detect t he to tal number 
of e x t r acellular and int racellula r immunoreactive EGF recep-
tor s. This IR-EGF/ R procedure was performed on cryostat 
sectioned, detergent permeabilized ti ssues using an ant i-EGF 
recept or ant ibody which recogni zes bot h occupied and unoc-
cupie d EGF recepto rs, precursor forms of the EGF receptor, 
and d egraded forms of the EGF receptor [23). However, thi s 
IR-EG F/ R procedure might also detect ot her prote ins that a re 
antigenically related to the EGF receptor. Therefore, t hese two 
meth o ds were useful to determine whether t he EGF receptor 
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FIG 11. lmmunoperox idase sta ining of a n apoc ri ne sweat ala nd A 
This experimental section indica tes t hat t he myoepi t helial" cells. oi· 
apocrine gla nds ~1 l so conta in EGF receptors (arrows). T he seve rely 
dis rupted secretory ep it helia l ce lls are lightly stained. B, T he lgG 
control section co nta ins no background sta inin g reaction in t he secre-
to ry epi t helium or t he myoepi thelia l cell s. Calibration bar= 50 J.<ll1. 
localization as detected by one method could be validated by 
the other or whether a rt ifactual resul ts were being produced. 
Using these two light microscopic methods, we have made 
the fo llowing observations. In human ski n, the highest detect-
able levels of [' 2' I]EGF/ R a nd IR-EGF/ R were seen in t he 
dermal ducts of ecc rin e sweat glands. In t he epidermis itself, 
keratinocytes from t he s. basalis showed high levels of ['2''I] 
EGF/ R and IR-E GF/ R. The latter findin g confi rms our earlier 
resul ts using a di fferent ul t rastructural, immunocytochemica l 
method [7]. In t he pilosebaceous uni ts , t he epidermal cells 
presumed to represent the proli fe rative, mi togen-responsive 
cell s had significant levels of [' "''I) EGF/R and IR-EG F/R. 
However, other skin structures which are not greatly involved 
in cell replication, but presumably have high metabolic activity, 
were a lso found to have [' 2"I]EGF/R and IR-EGF/ R; e.g., 
arrector pili muscles, eccrine sweat ducts, tunica media of 
dermal arteries, and myoepit helia l cells. Thus, the association 
of the presence of EGF receptors with proli fe rative cells only 
refl ects certain, but not all , subsets of cell populat ions in the 
skin. 
Interestingly, [' "·'I)EGF/R and IR-EG F/ R were not always 
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detectable on cells or in s ites where E GF binding has been 
detected in vi t ro, i.e., fi broblasts [14]. These differences may 
be due to t he condi t ions induced by growing fibroblasts in vi t ro 
(norm al adul t huma n de rm a l fibroblasts a re not metabolically 
very act ive) [21,30), t he possibili ty t hat fibroblasts may express 
a sma ll number of EG F receptors compared to other cell s 
[31 ,32], or t he re lative insensit ivity of our methods. 
[' 1''1]EGF/ R a nd IR-EGF/ R were detected for the first t ime 
on smooth muscle ce ll s in huma n skin . The probable presence 
of E GF receptors on smooth muscle cells may be inferred from 
the report t hat smooth muscle cells in cul ture respond to E GF 
[33]. EG F also may be invol ved in skeleta l muscle development 
since EGF binding capacity decreased in te rminally di fferen-
t iated skeleta l myoblasts [34 ]. What pa rt EGF may play in 
muscle function is unclear bu t may relate to its effect s on 
ca lcium metabo lism a nd phosphatidyl inositol turnove r [35]. 
T he p resence of EGF receptors, as localized by t hese two 
methods, in other skin sites, e.g., sebaceous glands, may be 
physiologically s ignifican t . EGF injections in to ha msters stim-
ul ated sebaceous gland secretion a nd cell growth (36]. T he 
presen t studies indicate t hat sebocytes have EGF receptors, 
t hereby im plying t hat t hese were direct effects of EGF on 
sebocytes. Testosterone injections increase E GF p roduction 
a nd secretion by the saliva ry gla nds in mice [37]. Testosterone 
a lso affects sebaceous gla nds in several species [38]. Therefore, 
the in teraction of testosterone and EGF activity in t he physi-
ologic hyp ertrophy of sebaceous gla nds a t puberty and in t he 
pathogenesis of ac ne vulgari s is of in te rest. E GF a lso a ffects 
another compon ent of t he p il osebaceous unit, t he hair follicle 
itse lf. The influence of EGF on ha ir developmen t a nd t he ha ir 
growth cycle was previously reported [39,40] . Exogenous ad -
ministration of EGF inhibi ts hair growth (41] a nd in sheep 
leads to a wea kness in t he hair (wool) fibers thereby a llowing 
fl eece to be sheared by ha nd [ 42]. The localization of [11''1] 
EGF/ R and IR-EGF/R in t he outer root sheath cells and hair 
matrix cell s implies t hat EGF is directly in volved in t he huma n 
ha ir cycle. Whether male-patte rn a lopec ia is related to t he 
direct or indirect effects o f testosterone acting on E GF a nd/or 
EG F receptor metaboli sm in suscept ib le ha ir follicle cells 
should be studied . 
T he very high level of [' 2''I] EGF/R a nd IR-EGF/R in dermal 
ducts of eccrine sweat gla nds is in t riguing since it is known 
t hat EGF / urogastrone plays a regul atory role in gastric acid 
secretion [43- 45 ] a nd t hus may play a role in t he chloride 
secretion in huma n sweat. Another possib le function of t he 
EGF recep to r in t he ducta l ce lls may be to t ra nsport E GF into 
t he ductal lumen . The physiologic s ignificance of these E GF 
recepto rs is supported by t he presence of EGF in hum a n sweat 
[46,47]. Furt her study is necessary to sort out t hese a nd other 
possibili t ies to expla in why t hese ductal cells have such high 
levels of E GF receptors. 
T he EGF binding site, endoge nous or a utophosphory lation 
sites, a nd ty rosy l p rote in kin ase are functionally located on the 
same molecul e or complex (24,48). The a n t i-E GF receptor 
an t ibody used in t he prese nt study immunoprecipi tates recep -
tors which also had EGF -stimulated tyros ine kin ase ac tivi ty 
[23,24 ]. Therefore, t he immunocytochemical method not only 
locali zes t he IR-EGF / R but should also re f1ect t he pattern of 
EG F -stimulated tyrosyl kinase in undegraded molecules . 
Whether t he IR-EGF/ R prec isely refl ects tyrosi ne kinase ac-
t ivity cannot be dete rmin ed accurately in s it u wit hout direct 
measurements with di ffere nt cytoc hemical or biochemi cal 
methods. S ince [' ~'' I] EGF/R a nd IR-EGF / R both decreased in 
keratinocytes as epiderm a l diffe rent iation increased, it may be 
important t hat t he EGF -stimulated tyrosyl kinases be reduced 
to a ll ow norma l di ffe rent iation to occur. Ty rosyl kinases may 
have a n important role in ce ll p roliferation since vira lly t ra ns-
formed cells have increased tyrosyl kinase act ivity and other 
growth-promoting substances or mi togens such as insulin and 
p latelet-derived growth factor stimulate tyrosine kinase activity 
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[49). S ince the presence of tyrosine kinases has a lso been 
observed in norm al cells t hat do not have a hi gh prolife rative 
capacity [50], its role may be to ma intain the cell in a meta-
bo lically active state. M ore direct evidence is becomin g avail -
able indicating t hat t he regulation ofEGF receptor binding a n d 
tyrosine kinase activity is important in skin in vivo . For ex-
ample, [115I]EGF/ R a nd IR-EGF / R persist or a re aberra ntly 
regu lated in benign (psorias is) [51) a nd ma lignan t (carcinom a) 
hyperproli ferat ive di seases of the skin (Na nney, King a nd 
Stoscheck, unpublis hed observations). 
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